Kåre Schultz, Teva CEO (Christopher Goodney/Bloomberg via Getty Images)
Teva CEO Kåre Schultz sees a 35% raise despite the company's continued legal woes
Amid a year where revenues were mostly flat but lawsuits continued piling up, Teva CEO Kåre Schultz saw himself getting a raise.
In shareholder …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
